Stay updated on Ublituximab in RMS: Clinical Trial

Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ublituximab in RMS: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed ULTIMATE II study is now displayed instead of an error page. It provides the study design and treatment arms, participant criteria, outcome measures, locations, publications, and study documents.
    Difference
    55%
    Check dated 2026-11-08T14:47:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A general NIH notice was added above the site navigation, pointing visitors to transition updates and explaining the shift from “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T19:30:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:42:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.0 to v3.7.1; the study details remain inaccessible on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:37:31.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content and navigation with an access-restricted screen. This indicates the record is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-20T20:09:37.000Z thumbnail image

Stay in the know with updates to Ublituximab in RMS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.